Home / Companies / Q3 Fy19 Results /  GlaxoSmithKline Pharma Q3 net profit up 26% at 113 crore

New Delhi: Drug firm GlaxoSmithKline Pharmaceuticals Monday reported a 26 per cent rise in its standalone net profit at 112.97 crore for the quarter ended December 31, 2018, mainly on account of one-time gain of 28 crore.

The company had posted a net profit of 89.69 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a filing to BSE.

Standalone revenue from operations of the company stood at 825.35 crore for the quarter under consideration as against 703.91 crore for the same period a year ago.

Commenting on the results, GlaxoSmithKline Pharmaceuticals MD A Vaidheesh said, "The business embarked on its new strategy this year, as we put in place an optimal commercial structure and worked at building capability."

New commercial model of the company is in place, with increased focus on priority brands, and expansion in field force to drive this focus, including a new trade channel strategy, he added.

"Our financial performance highlights the outcomes of this execution with a headline double digit sales growth both for the quarter and year to date, underpinned by a strong volume delivery," Vaidheesh said.

Exceptional items for the quarter ended December 31, 2018, comprise profit from sale of property of 23 crore and non-core brand divestments contributing 5 crore."

Shares of GlaxoSmithKline Pharmaceuticals ended at 1,402.30 per scrip on BSE, down 0.35 per cent from its previous close.

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less

Recommended For You

Trending Stocks

×
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout